Patent details
EP2132201 Title: NOVEL 2-HETEROARYL SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANES
Basic Information
- Publication number:
- EP2132201
- PCT Application Number:
- PCT/SE/2008/050243
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087241907
- PCT Publication Number:
- WO/2008/108730
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NOVEL 2-HETEROARYL SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANES
- French Title of Invention:
- NOUVEAUX BENZOTHIOPHÈNES ET BENZOFURANES À SUBSTITUTION 2-HÉTÉROARYLE
- German Title of Invention:
- NEUARTIGE 2-HETEROARYL-SUBSTITUIERTE BENZOTHIOPHENE UND BENZOFURANE
- SPC Number:
Dates
- Filing date:
- 05/03/2008
- Grant date:
- 16/11/2016
- EP Publication Date:
- 16/11/2016
- PCT Publication Date:
- 12/09/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/12/2009
- EP B1 Publication Date:
- 16/11/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/03/2017
- Expiration date:
- 05/03/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/03/2008
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- WENSBO David
- Address:
- Sweden (SE)
2
- Name:
- SWAHN Britt-Marie
- Address:
- Sweden (SE)
3
- Name:
- ARZEL Erwan
- Address:
- Sweden (SE)
Priority
- Priority Number:
- 893149 P
- Priority Date:
- 06/03/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 405/04;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|